Yong‐Man Kim

796 total citations
25 papers, 577 citations indexed

About

Yong‐Man Kim is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Yong‐Man Kim has authored 25 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Yong‐Man Kim's work include Cervical Cancer and HPV Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yong‐Man Kim is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yong‐Man Kim collaborates with scholars based in South Korea, United States and Italy. Yong‐Man Kim's co-authors include Young‐Tak Kim, Joo‐Hyun Nam, Moo‐Ho Won, Dong Heon Lee, Kwon‐Soo Ha, Sung Mo Hur, Hyun Soo Kim, Young‐Guen Kwon, Jong-Hyeok Kim and CK Kim and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and PLoS ONE.

In The Last Decade

Yong‐Man Kim

23 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yong‐Man Kim South Korea	10	246	109	99	94	92	25	577
Alexandra Friemel Germany	15	223 0.9×	100 0.9×	113 1.1×	67 0.7×	36 0.4×	24	519
Erika Márton Austria	14	326 1.3×	93 0.9×	241 2.4×	94 1.0×	36 0.4×	15	716
Laureano Simón Spain	13	207 0.8×	37 0.3×	113 1.1×	119 1.3×	38 0.4×	29	660
Robert H. Gersh United States	7	190 0.8×	84 0.8×	151 1.5×	30 0.3×	54 0.6×	8	501
Ljiljana Šerman Croatia	13	723 2.9×	55 0.5×	193 1.9×	70 0.7×	55 0.6×	45	984
Tania L. Slatter New Zealand	21	435 1.8×	98 0.9×	269 2.7×	42 0.4×	56 0.6×	47	801
Mélanie Briand France	16	274 1.1×	78 0.7×	139 1.4×	57 0.6×	37 0.4×	35	648
Ross S. Berkowitz United States	12	183 0.7×	60 0.6×	131 1.3×	74 0.8×	19 0.2×	17	627
Charlotte Hill United Kingdom	11	270 1.1×	28 0.3×	97 1.0×	40 0.4×	137 1.5×	25	613
Nisreen Abu Shahin Jordan	12	138 0.6×	25 0.2×	62 0.6×	67 0.7×	33 0.4×	40	466

Countries citing papers authored by Yong‐Man Kim

Since Specialization

Citations

This map shows the geographic impact of Yong‐Man Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Man Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Man Kim more than expected).

Fields of papers citing papers by Yong‐Man Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Man Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Man Kim. The network helps show where Yong‐Man Kim may publish in the future.

Co-authorship network of co-authors of Yong‐Man Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Man Kim. A scholar is included among the top collaborators of Yong‐Man Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Man Kim. Yong‐Man Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bae, Kyun‐Seop, et al.. (2025). First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors. Cancer Medicine. 14(4). e70576–e70576. 1 indexed citations

Duska, Linda, Yang Xiang, Kosei Hasegawa, et al.. (2025). Pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer: Final analysis results of the phase 3, randomized, double-blind ENGOT-cx11/GOG-3047/KEYNOTE-A18 study.. Journal of Clinical Oncology. 43(17_suppl).

Kim, Byoung‐Gie, Ji‐Yeob Choi, Jae‐Weon Kim, et al.. (2023). Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE). Cancer Medicine. 12(7). 8742–8753. 6 indexed citations

Kim, Min Kyu, Hyun‐Ki Kim, Sunyoung Ahn, et al.. (2020). Performance evaluation of an amplicon‐based next‐generation sequencing panel for BRCA1 and BRCA2 variant detection. Journal of Clinical Laboratory Analysis. 34(12). e23524–e23524. 5 indexed citations

Kim, Hyun‐Ki, Sunyoung Ahn, Young-Jae Lee, et al.. (2020). GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of BRCA1 and BRCA2.. PubMed. 50(1). 107–118. 1 indexed citations

Kim, Yong‐Man, et al.. (2018). Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer. Obstetrics & Gynecology Science. 61(3). 328–328. 24 indexed citations

Lee, Ha‐Young, et al.. (2016). Abstract B04: Early detection of ovarian cancer recurrence using p53-mutated circulating tumor DNA as non-invasive biomarkers.. Clinical Cancer Research. 22(2_Supplement). B04–B04. 2 indexed citations

Min, Kyung‐Jin, Yoon Jae Lee, Mina Suh, et al.. (2015). The Korean guideline for cervical cancer screening. Journal of Gynecologic Oncology. 26(3). 232–232. 61 indexed citations

Kim, Yong‐Man, Shin‐Wha Lee, Sung‐Min Chun, et al.. (2014). Analysis and Comparison of Somatic Mutations in Paired Primary and Recurrent Epithelial Ovarian Cancer Samples. PLoS ONE. 9(6). e99451–e99451. 16 indexed citations

10.

Hur, Sung Mo, CK Kim, Yong‐Man Kim, et al.. (2014). Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. Vascular Pharmacology. 63(1). 19–28. 159 indexed citations

11.

Lee, Shin‐Wha, et al.. (2013). Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells. European Journal of Obstetrics & Gynecology and Reproductive Biology. 169(1). 75–79. 2 indexed citations

12.

Lee, Hwa‐Young, Bong‐Min Yang, Jimin Hong, et al.. (2013). Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model.. 5. 297–307. 2 indexed citations

13.

Lee, Youn Soo, Gyungyub Gong, Jin Hee Sohn, et al.. (2013). Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath. The Korean Journal of Pathology. 47(3). 265–265. 3 indexed citations

14.

Koo, Yu‐Jin, et al.. (2013). Vaginal cuff dehiscence after hysterectomy. International Journal of Gynecology & Obstetrics. 122(3). 248–252. 13 indexed citations

15.

Bae, Jeehyeon, Miae Won, Dae‐Yeon Kim, et al.. (2012). Identification of Differentially Expressed MicroRNAs in Endometrial Cancer Cells After Progesterone Treatment. International Journal of Gynecological Cancer. 22(4). 561–565. 17 indexed citations

16.

Pak, Jhang Ho, Won‐Ho Choi, Hye Mi Lee, et al.. (2010). Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells. Cancer Investigation. 29(1). 21–28. 67 indexed citations

17.

Park, Boyoung, Sohee Park, Tae‐Joong Kim, et al.. (2010). Epidemiological characteristics of ovarian cancer in Korea. Journal of Gynecologic Oncology. 21(4). 241–241. 34 indexed citations

18.

Shin, Dong Wook, Eun‐Mi Ahn, Yong‐Man Kim, et al.. (2009). Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module. Oncology. 76(3). 190–198. 21 indexed citations

19.

Kim, Young Tae, et al.. (2007). 대한부인종양ㆍ콜포스코피학회의 4가 인유두종 바이러스 백신 접종 권고안. Journal of Gynecologic Oncology. 18(4). 259–283. 2 indexed citations

20.

Lee, Kee Nyung, Hyung‐Sik Kang, Jun-Ho Jeon, et al.. (2005). VDUP1 Is Required for the Development of Natural Killer Cells. Immunity. 22(2). 195–208. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact